Head and Neck Cancer Trial, Recruiting NCT07337161 Sponsor: David Palma Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT07337161
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older
  • People who are able to give informed consent to participate
  • People who are well enough to carry out everyday activities with little or no limitation (this is measured using a standard scale called ECOG, scores 0–2)
  • People whose cancer is being treated with the goal of cure
  • People who can read and understand English well enough to fill in questionnaires about how they are feeling
  • People who have been diagnosed with a type of skin cancer called cutaneous squamous cell carcinoma (SCC), confirmed by a tissue sample (biopsy)
  • People who have had surgery to fully remove a primary skin cancer tumour in the head or neck area
  • People whose tumour is at a certain stage of size or spread (stages T1–T4 under a standard cancer staging system), or whose tumour stage is unknown but who have a cancer-positive lymph node near the ear or in the neck that the treating doctor believes came from a head and neck skin SCC
  • People whose cancer has spread to nearby lymph nodes at a certain level (stages N1–N3 under the same staging system)
  • People who have at least one reason why additional radiation treatment after surgery would be recommended, such as: a larger tumour (T3 or T4); cancer found in blood or lymph vessels within the tissue; cancer found along nerve pathways in the tissue; surgical margins that were positive or very close to cancer cells (3mm or less); one or more positive lymph nodes near the ear or in the neck; or cancer that has come back more than once or appeared in multiple spots
  • People who have received or are receiving immunotherapy (before or after surgery) may also be eligible

Who may not be able to join:

  • People whose cancer has clearly spread to distant parts of the body at the time of diagnosis
  • People who are pregnant or breastfeeding
  • People with serious health conditions or other medical reasons that would make surgery or radiation unsafe
  • People who have had a previous head or neck cancer within the last 5 years — though a history of localised skin cancers that had not spread to lymph nodes or elsewhere may not exclude someone (confirm with trial site)
  • People who have previously had radiation to the same side of the head or neck involving the parotid gland (near the ear) or nearby lymph nodes — though prior radiation directly to the skin cancer being treated in this trial may be acceptable if there is no meaningful overlap with the new radiation area, as judged by the treating doctor (confirm with trial site)
  • People whose cancer has spread to lymph nodes on the opposite side of the neck, which would require radiation to that side
  • People who have had another serious (invasive) cancer within the past 5 years, unless that cancer has been treated and there is no current evidence of it

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 519-685-8500

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
David Palma
Registry
ClinicalTrials.gov
Start date
21 October 2025
Est. completion
1 September 2030

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Tumor control

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov